Morphotek, Wyeth-Ayerst cancer deal

Wyeth-Ayerst, the pharmaceutical division of American Home Products (AHP), will use the Direct-Line cell evolution technology from Morphotek (Philadelphia, Penn.) to develop cell lines for internal ca...